STATE-OF-THE-ART PAPER
Long QT Syndrome
Ilan Goldenberg, MD* and
Arthur J. Moss, MD
Cardiology Division, Department of Medicine, University of Rochester Medical Center, Rochester, New York.
Manuscript received December 31, 2007;
revised manuscript received February 19, 2008,
accepted February 26, 2008.
* Reprint requests and correspondence: Dr. Ilan Goldenberg, Heart Research Follow-up Program, University of Rochester Medical Center, 601 Elmwood Avenue, Box 653, Rochester, New York 14642-8653. (Email: Ilan.Goldenberg{at}heart.rochester.edu).
The hereditary long QT syndrome (LQTS) is a genetic channelopathy with variable penetrance that is associated with increased propensity to syncope, polymorphous ventricular tachycardia (torsades de pointes), and sudden arrhythmic death. This inherited cardiac disorder constitutes an important cause of malignant ventricular arrhythmias and sudden cardiac death in young individuals with normal cardiac morphology. Risk assessment in affected LQTS patients relies upon a constellation of electrocardiographic, clinical, and genetic factors. Administration of beta-blockers is the mainstay therapy in affected patients, and primary prevention with an implantable cardioverter defibrillator or left cervicothoracic sympathetic denervation are therapeutic options in patients who remain symptomatic despite beta-blocker therapy. Accumulating data from the International LQTS Registry have recently facilitated a comprehensive analysis of risk factors for aborted cardiac arrest or sudden cardiac death in pre-specified age groups, including the childhood, adolescence, adulthood, and post-40 periods. These analyses have consistently indicated that the phenotypic expression of LQTS is time dependent and age specific, warranting continuous risk assessment in affected patients. Furthermore, the biophysical function, type, and location of the ion-channel mutation are currently emerging as important determinants of outcome in genotyped patients. These new data may be used to improve risk stratification and for the development of gene-specific therapies that may reduce the risk of life-threatening cardiac events in patients with this inherited cardiac disorder.
|
Abbreviations and Acronyms
| | ACA = aborted cardiac arrest | | ECG = electrocardiogram | | ICD = implantable cardioverter-defibrillator | | LCSD = left cervicothoracic sympathetic denervation | | LQTS = long QT syndrome | | QTc = corrected QT | | SCD = sudden cardiac death |
|
This article has been cited by other articles:
|
|
|
|
 
P. J. Schwartz, M. Stramba-Badiale, L. Crotti, M. Pedrazzini, A. Besana, G. Bosi, F. Gabbarini, K. Goulene, R. Insolia, S. Mannarino, et al.
Prevalence of the Congenital Long-QT Syndrome
Circulation,
November 3, 2009;
120(18):
1761 - 1767.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Developed in collaboration with, European Heart Rhythm Association (EHRA), Heart Failure Association (HFA), and Heart Rhythm Society (HRS), Endorsed by the following societies, European Society of Emergency Medicine (EuSEM), European Federation of Internal Medicine (EFIM), European Union Geriatric Medicine Society (EUGMS), American Geriatrics Society (AGS), European Neurological Society (ENS), et al.
Guidelines for the diagnosis and management of syncope (version 2009): The Task Force for the Diagnosis and Management of Syncope of the European Society of Cardiology (ESC)
Eur. Heart J.,
November 1, 2009;
30(21):
2631 - 2671.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. M. Goldman, E. Glasscock, J. Yoo, T. T. Chen, T. L. Klassen, and J. L. Noebels
Arrhythmia in Heart and Brain: KCNQ1 Mutations Link Epilepsy and Sudden Unexplained Death
Science Translational Medicine,
October 14, 2009;
1(2):
2ra6 - 2ra6.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M S Link
Prevention of sudden cardiac death: return to sport considerations in athletes with identified cardiovascular abnormalities
Br. J. Sports Med.,
September 1, 2009;
43(9):
685 - 689.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. M. Marcus, E. Keung, and M. M. Scheinman
The year in review of clinical cardiac electrophysiology.
J. Am. Coll. Cardiol.,
August 25, 2009;
54(9):
777 - 787.
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Spazzolini, J. Mullally, A. J. Moss, P. J. Schwartz, S. McNitt, G. Ouellet, T. Fugate, I. Goldenberg, C. Jons, W. Zareba, et al.
Clinical Implications for Patients With Long QT Syndrome Who Experience a Cardiac Event During Infancy.
J. Am. Coll. Cardiol.,
August 25, 2009;
54(9):
832 - 837.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Shephard and C. Semsarian
Advances in the prevention of sudden cardiac death in the young
Therapeutic Advances in Cardiovascular Disease,
April 1, 2009;
3(2):
145 - 155.
[Abstract]
[PDF]
|
|
|
|
|
|
|
E. LEVINE and J. P. DAUBERT
IN REPLY:
Cleveland Clinic Journal of Medicine,
February 1, 2009;
76(2):
88 - 88.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. N. DeMaria, O. Ben-Yehuda, J. J. Bax, G. K. Feld, B. H. Greenberg, W. Y.W. Lew, J. A.C. Lima, A. S. Maisel, S. M. Narayan, D. J. Sahn, et al.
Highlights of the Year in JACC 2008.
J. Am. Coll. Cardiol.,
January 27, 2009;
53(4):
373 - 398.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Viskin and A. Halkin
Treating the Long-QT Syndrome in the Era of Implantable Defibrillators
Circulation,
January 20, 2009;
119(2):
204 - 206.
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. G. Cosío, J.#x. Palacios, A.#x.;n Pastor, and A. Núñez
CHAPTER 2 The Electrocardiogram
ESC Textbook of Cardiovascular Medicine,
January 1, 2009;
2(1):
med-9780199566990-chapter - med-9780199566990-chapter.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. R. Kapoor
Inherited Long QT Syndromes: Be Mindful of the Potassium Level
J. Am. Coll. Cardiol.,
November 4, 2008;
52(19):
1605 - 1605.
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Goldenberg and A. J. Moss
Reply
J. Am. Coll. Cardiol.,
November 4, 2008;
52(19):
1605 - 1606.
[Full Text]
[PDF]
|
|
|
|
